Symbols

SPRO

Spero Therapeutics·NASDAQ

--(--)

7.63 / 10

Outperform

No analyst coverage is recorded. Fund‑flow rating is bullish (7.63/10) with strong small, medium and large inflows, though overall and block trends are negative and extra‑large inflow is weak. Liquidity sentiment is positive.

Fund Flow Rating

What is the market sentiment for SPRO?

SPRO holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.63/10 (Outperform).